유방암 환자에게 항암화학요법 후 발생하는말초신경병에서 Total Neuropathy Score-Reduced와여러 전기생리학적검사 소견들과의 연관성
The Correlation of the Grading of Chemotherapy-Induced Peripheral Neurotoxicity (CIPN) Using the Total Neuropathy Score-Reduced and Various Electrophysiological Parameters in Breast Cancer Patients
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The accurate grading of chemotherapy-induced peripheral neuropathy (CIPN) represents an unsolved issue. This study evaluated usefulness of the reduced version of Total Neuropathy Score TNS (TNSr) and the correlation of this scale with various electrophysiological parameters. Methods: Neuropathic symptoms and quality of life were assessed using the neuropathy symptom scale and the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity (FACT/GOG-NTX) scale. A detailed neurologic examination, nerve conduction study (NCS), and the current perception threshold (CPT) were also performed. The TNSr score was calculated by a single examiner. We divided the patients with small fiber neuropathy and large fiber neuropathy and compared each variable between groups. Also, we analyzed correlations of the TNSr score with various parameters (NCS data, CPT score, and neuropathy symptom scales). Results: Of 30 recruited patients, 16 (53%) had large fiber neuropathy, and the other 14 (47%) had small fiber neuropathy. Patients with large fiber neuropathy had a lower sural sensory nerve action potential (SNAP) (p=0.000), lower peroneal compound muscle action potential (CMAP) (p=0.002), higher National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE, NTC) sensory grade (p=0.029) and higher TNSr score (p=0.000). There were no differences in any domain of the FACT/G, neuropathy symptom scale, or FACT/GOG-NTX between the two groups. The TNSr score was most significantly correlated with the sural SNAP (p=0.000), NTC-sensory grade (p=0.000), neuropathy symptom scale (p=0.001), FACT/GOG-NTX score (p=0.009), and pin score (p=0.002). Conclusions: The TNSr score is correlated with sensory peripheral neurotoxicity and also present the symptom severity in CIPN.
Abstract
Background: The accurate grading of chemotherapy-induced peripheral neuropathy (CIPN) represents an unsolved issue. This study evaluated usefulness of the reduced version of Total Neuropathy Score TNS (TNSr) and the correlation of this scale with various electrophysiological parameters. Methods: Neuropathic symptoms and quality of life were assessed using the neuropathy symptom scale and the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity (FACT/GOG-NTX) scale. A detailed neurologic examination, nerve conduction study (NCS), and the current perception threshold (CPT) were also performed. The TNSr score was calculated by a single examiner. We divided the patients with small fiber neuropathy and large fiber neuropathy and compared each variable between groups. Also, we analyzed correlations of the TNSr score with various parameters (NCS data, CPT score, and neuropathy symptom scales). Results: Of 30 recruited patients, 16 (53%) had large fiber neuropathy, and the other 14 (47%) had small fiber neuropathy. Patients with large fiber neuropathy had a lower sural sensory nerve action potential (SNAP) (p=0.000), lower peroneal compound muscle action potential (CMAP) (p=0.002), higher National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE, NTC) sensory grade (p=0.029) and higher TNSr score (p=0.000). There were no differences in any domain of the FACT/G, neuropathy symptom scale, or FACT/GOG-NTX between the two groups. The TNSr score was most significantly correlated with the sural SNAP (p=0.000), NTC-sensory grade (p=0.000), neuropathy symptom scale (p=0.001), FACT/GOG-NTX score (p=0.009), and pin score (p=0.002). Conclusions: The TNSr score is correlated with sensory peripheral neurotoxicity and also present the symptom severity in CIPN.
참고문헌 (22)
- Edwards BK, "Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment", J Natl Cancer Inst, 97, pp.1407~1427 (2005)
- Roytta M, "Taxol-induced neuropathy : further ultrastructural studies of nerve fibre changes in situ", J Neurocytol, 14, pp.157~175 (1985)
- Polomano RC, "A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel", Pain, 94, pp.293~304 (2001)
- Trotti A, "CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment", Semin Radiat Oncol, 13, pp.176~181 (2003)
- Cavaletti G, "Grading of chemotherapy-induced peripheral neurotoxicity using the total neuropathy scale", Neurology, 61, pp.1297~1300 (2003)
- Cavaletti G, "Multi-center assessment of the total neuropathy score for chemotherapy-induced peripheral neurotoxicity", J Peripher Nerv Syst, 11, pp.135~141 (2006)
- Chaudhry V, "Toxic neuropathy in patients with pre-existing neuropathy", Neurology, 60, pp.337~340 (2003)
- Cavaletti G, "Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy", Ann Oncol, 15, pp.1439~1442 (2004)
- Cavaletti G, "Thalidomide sensory neurotoxicity : a clinical and neurophysiologic study", Neurology, 62, pp.2291~2293 (2004)
- Thaisetthawatkul P, "Contribution of QSART to the diagnosis of small fiber neuropathy", Muscle Nerve, 48, pp.883~888 (2013)
- Blackmore D, "Diagnostic criteria for small fiber neuropathy", J Clin Neuromuscul Dis, 18, pp.125~131 (2017)
- Bell-Krotoski JA, "Threshold detection and semmes-weinstein monofilaments", J Hand Ther, 8, pp.155~162 (1995)
- de Sonnaville JJ, "The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting", Diabetes Res Clin Pract, 35, pp.149~156 (1997)
- Felix ER, "Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain", J Rehabil Res Dev, 46, pp.69~83 (2009)
- Martina IS, "Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European inflammatory neuropathy cause and treatment (INCAT) group", J Neurol Neurosurg Psychiatry, 65, pp.743~747 (1998)
- Pestronk A, "Sensory exam with a quantitative tuning fork : rapid, sensitive and predictive of SNAP amplitude", Neurology, 62, pp.461~464 (2004)
- Oh SJ, "Clinical electromyography: nerve conduction studies", pp.517~526 (1993), Williams & Wilkins
- "Technology review: the neurometer current perception threshold (CPT). AAEM equipment and computer committee. American association of electrodiagnostic medicine", Muscle Nerve, 22, pp.523~531 (1999)
- Low PA, "Quantitative sudomotor axon reflex test in normal and neuropathic subjects", Ann Neurol, 14, pp.573~580 (1983)
- Huang HQ, "Validation and reduction of FACT", GOG-Ntx subscale for platinum, Int J Gynecol Cancer, pp.2007, 17[DOI]
- Calhoun EA, "Psychometric evaluation of the functional assessment of cancer therapy", gynecologic oncology group-neurotoxicity(Fact, Int J Gynecol Cancer, pp.2003, 13[DOI]
- 윤동주, "신경병통증의 선별과 척도화를 위한 한국어 신경병통증설문지 개발: 예비연구", 대한신경과학회지, 30(1), pp.15~25 (2012), 대한신경과학회